Sildenafil is indicated for treating pulmonary arterial hypertension (PAH). Unipharm’s generic Sildenafil Citrate Tablets for PAH have been manufactured and marketed in Israel since 2013.
ATC4: G04BE
Strengths: 20 mg
Dosage form: Tablets
Out-licensing is offered for all international markets*
Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect
